Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Your RPS

New RPS 'reclassifications hub' offers guidance on supply of P medicines

reclassifications hub royal pharmaceutical society website 17

Source: RPS

The Royal Pharmaceutical Society has launched an online hub for pharmacists selling or supplying medicines reclassified from ‘prescription only’ to ‘pharmacy’ status

An online hub giving guidance to pharmacists who sell or supply medicines that have been reclassified from prescription-only medicine (POM) to pharmacy (P) status has been launched by the Royal Pharmaceutical Society (RPS). 

The reclassifications hub offers guidance to RPS members selling products which have been reclassified from POM to P, meaning that they should only be sold in a registered pharmacy under the supervision of a pharmacist.

The hub, accessible via the RPS website, includes drug indications, side effects and interactions, as well as advice on when a customer seeking to purchase a P medicine should be referred to their GP.

Currently, the hub features eight medicines, including weight loss drug orlistat, chloramphenicol eye drops and the migraine relief medication, sumatriptan.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202731

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • reclassifications hub royal pharmaceutical society website 17

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.